Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening

Journal of Medicinal Chemistry

Volumn 51, Issue 23, 2008, Pages 7442-7448

  Kovač, Andreja ^a   Konc, Janez ^b   Vehar, Blaž ^b   Bostock, Julieanne M ^c   Chopra, Ian ^c   Janežič, Dušanka ^b   Gobec, Stanislav ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO ALANINE DEXTRO ALANINE LIGASE; LIGASE INHIBITOR; NSC 130813; NSC 176327; NSC 86005; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; COMPUTER PROGRAM; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRUCTURE ANALYSIS;

CATALYTIC DOMAIN; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HYDROGEN BONDING; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PEPTIDE SYNTHASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57349130997     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800726b     Document Type: Article

References (52)

1. Labischinski, H.; Maidhof, H. Bacterial Peptidoglycan: Overview and Evolving Concepts. In Bacterial Cell Wall; Ghuysen, J.-M., Hakenbeck, R., Eds.; Elsevier: Amsterdam, 1994; pp 23-38.
2. Barreteau, H.; Kovač, A.; Boniface, A.; Sova, M.; Gobec, S.; Blanot, B. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol. Rev. 2008, 32, 168-207.
3. Kahan, F. M.; Kahan, J. S.; Cassidy, P. J.; Kropp, H. The mechanism of action of fosfomycin (phosphonomycin). Ann. N.Y. Acad. Sci. 1974, 235, 364-386.
4. Neuhaus, F. C.; Lynch, J. L. The enzymatic synthesis of D-alanyl-D-alanine. III. On the inhibition of D-alanyl-D-alanine synthetase by the antibiotic D-cycloserine. Biochemistry 1964, 3, 471-479.
5. Walsh, C. T. Enzymes in the D-alanine branch of the bacterial cell wall peptidoglycan assembly. J. Biol. Chem. 1989, 264, 2393-2396.
6. Zawadzke, L. E.; Bugg, T. D. H.; Walsh, C. T. Existence of two D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymes. Biochemistry 1991, 30, 1673-1682.
7. Daub, E.; Zawadzke, L. E.; Botstein, D.; Walsh, C. T. Isolation, cloning, and sequencing of the Salmonella typhimurium ddlA gene with purification and characterization of its product, D-alanine:D-alanine ligase (ADP forming). Biochemistry 1988, 27, 3701-3708.
8. Healy, V. L.; Mullins, L. S.; Li, X.; Hall, S. E.; Raushel, F. M.; Walsh, C. T. D-Ala-D-X ligases: evaluation of D-alanyl phosphate intermediate by MIX, PIX, and rapid quench studies. Chem. Biol. 2000, 7, 505-514.
9. Mullins, L. S.; Zawadzke, L. E.; Walsh, C. T.; Raushel, F. M. Kinetic evidence for the formation of D-alanyl phosphate in the mechanism of D-alanyl-D-alanine ligase. J. Biol. Chem. 1990, 265, 8993-8998.
10. Neuhaus, F. C.; Carpenter, C. V.; Miller, J. L.; Lee, N. M.; Gragg, M.; Stickgold, R. A. Enzymatic synthesis of D-alanyl-D-alanine. Control of D-alanine:D-alanine ligase (ADP). Biochemistry 1969, 8, 5119-5124.
11. Healy, V. L.; Lessard, I. A; Roper, D. I.; Knox, J. R.; Walsh, C. T. Vancomycin resistance in enterococci: reprogramming of the D-Ala- D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol. 2000, 7, R109-R119.
12. Strominger, J. L.; Ito, E.; Threnn, R. H. Competitive inhibition of enzymatic reactions by oxamycin. J. Am. Chem. Soc. 1960, 82, 998-999.
13. Neuhaus, F. C.; Lynch, J. L. The enzymatic synthesis of D-alanyl-D-alanine. III. On the inhibition of D-alanyl-D-alanine synthetase by the antibiotic D-cycloserine. Biochemistry 1964, 3, 471-480.
14. Parsons, W. H.; Patchett, A. A.; Bull, H. G.; et al. Phosphinic acid inhibitors of D-alanyl-D-alanine ligase. J. Med. Chem. 1988, 31, 1772-1778.
15. Chakravarty, P. K.; Greenlee, W. J.; Parsons, W. H.; Patchett, A. A.; Combs, P.; Roth, A.; Busch, R. D.; Mellin, T. N. (3-Amino-2-oxoalkyl)phosphonic acids and their analogues as novel inhibitors of D-alanine:D- alanine ligase. J. Med. Chem. 1989, 32, 1886-1890.
16. Lacoste, A. M.; Chollet-Gravey, A. M.; Vo Quang, L.; Vo Quang, Y.; Le Goffic, F. Time-dependent inhibition of Streptococcus faecalisD- alanine:D-alanine ligase by α-aminophosphonamidic acids. Eur. J. Med. Chem. 1991, 26, 255-260.
17. Ellsworth, B. A.; Tom, N. J.; Bartlett, P. A. Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases. Chem. Biol. 1996, 3, 37-44.
18. Duncan, K.; Walsh, C. T. ATP-dependent inactivation and slow binding inhibition of Salmonella typhimuriumD-alanine:D-alanine ligase (ADP) by (aminoalkyi)phosphinate and aminophosphonate analogues of D-alanine. Biochemistry 1988, 27, 3709-3714.
19. McDermott, A. E.; Creuzet, F.; Griffin, R. G.; Zawadzke, L. E.; Ye, Q.-Z.; Walsh, C. T. Rotational resonance determination of the structure of an enzyme-inhibitor complex: phosphorylation of an (aminoalkyl)phosphinate inhibitor of D-alanyl-D-alanine ligase by ATP. Biochemistry 1990, 29, 5767-5775.
20. Fan, C.; Moews, P. C.; Walsh, C. T.; Knox, J. R. Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 Å resolution. Science 1994, 266, 439-443.
21. Fan, C.; Park, I. S.; Walsh, C. T.; Knox, J. R. D-Alanine: D-alanine ligase: phosphonate and phosphinate intermediates with wild type and the Y216F mutant. Biochemistry 1997, 36, 2531-2538.
22. Besong, G. E.; Bostock, J. M.; Stubbings, W.; Chopra, I.; Roper, D. I.; Lloyd, A. J.; Fishwick, C. W.; Johnson, A. P. A de novo designed inhibitor of D-Ala-D-Ala ligase from E. coli. Angew. Chem., Int. Ed. 2005, 44, 6403-6406.
23. Liu, S.; Chang, J. S.; Herberg, J. T.; Horng, M.-M.; Tomich, P. K.; Lin, A.; Marotti, K. R. Allosteric inhibition of Staphylococcus aureusD-alanine:D-alanine ligase revealed by crystallographic studies. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 15178-15183.
24. Kovač, A.; Majce, V.; Lenaršič, R.; Bombek, S.; Bostock, J. M.; Chopra, I.; Polanc, S.; Gobec, S. Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl). Bioorg. Med. Chem. Lett. 2007, 17, 2047-2054.
25. Triola, G.; Wetzel, S.; Ellinger, B.; Koch, M.; Hübel, K.; Rauh, D.; Waldmann H. ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds. Bioorg. Med. Chem. 2008, in press.
26. Kitchen, D. B.; Decornez, H.; Furr, J. R.; Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discovery 2004, 3, 935-949.
27. Vernhorst, J.; ter Laak, A. M.; Commandeur, J. N. M.; Funae, Y.; Hiroi, T.; Vermeulen, N. P. E. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J. Med. Chem. 2003, 46, 74-86.
28. Guido, R. V. C.; Oliva, G.; Andricopul, A. D. Virtual screening and its integration with modern drug design technologies. Curr. Med. Chem. 2008, 15, 37-46.
29. DeLano, W. L. The PyMOL Molecular Graphics System; DeLano Scientific LLC: Palo Alto, CA, 2007.http://www.pymol.org.
30. The NCI diversity set is available from the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI). The diversity set was selected from a larger repository of compounds at the NCI. See http://dtp.nci.nih.gov/branches/dscb/diversityexplanation.html.
31. Li, C.; Xu, L.; Wolan, D. W.; Wilson, I. A.; Olson, A. J. Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of autodock to identify novel nonfolate inhibitors. J. Med. Chem. 2004, 47, 6681-6690.
32. Brooks, W. H.; McCloskey, D. E.; Daniel, K. G.; Ealick, S. E.; Secrist, J. A., III; Waud, W. R.; Pegg, A. E.; Guida, W. C. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase. J. Chem. Inf. Model. 2007, 47, 1897-1905.
33. Li, C.; Xu, L.; Wolan, D. W.; Wilson, I. A.; Olson, A. J. Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. J. Med. Chem. 2004, 47, 6681-6690.
34. Rogers, J. P.; Beuscher, A. E.; Flajolet, M.; McAvoy, T.; Nairn, A. C.; Olson, A. J.; Greengard, P. Discovery of protein phosphatase 2C inhibitors by virtual screening. J. Med. Chem. 2006, 49, 1658-1667.
35. McGovern, S. L.; Helfand, B. T.; Feng, B.; Shoichet, B. K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 2003, 46, 4265-4272.
36. 1A orthologs. Biochemistry 2007, 46, 2640-2654.
37. Källblad, P.; Mancera, R. L.; Todorov, N. P. Assessment of multiple binding modes in ligand-protein docking. J. Med. Chem. 2004, 47, 3334-3337.
38. Kozakov, D.; Clodfelter, K. H.; Vajda, S.; Camacho, C. J. Optimal clustering for detecting near-native conformations in protein docking. J. Med. Chem. 2005, 89, 867-875.
39. Limongelli, V.; Marinelli, L.; Cosconati, S.; Braun, H. A.; Schmidt, B.; Novellino, E. Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design. Chem. Med. Chem. 2007, 2, 667-678.
40. Rosenfeld, R. J.; Goodsell, D. S.; Musah, R. A.; Morris, G. M.; Goodin, D. B.; Olson, A. J. Automated docking of ligands to an artificial active site: augmenting crystallographic analysis with computer modeling. J. Comput. - Aided Mol. Des. 2003, 17, 525-536.
41. O'Neill, A. J.; Bostock, J. M.; Morais Moita, A.; Chopra, I. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J. Antimicrob. Chemother. 2002, 50, 839-848.
42. Kelder, J.; Grootenhuis, P. D. J.; Bayada, D. M.; Delbressine, L. P. C.; Ploemen, J.-P. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 1999, 16, 1514-1519.
43. Hütter, K.; Baader, E.; Frobel, K.; Zeeck, A.; Bauer, K.; Gau, W.; Kurz, J.; Schröder, T.; Wünsche, C.; Karl, W.; Wendisch, D. Viriplanin A, a new anthracycline antibiotic of the nogalamyci group. J. Antibiot. 1986, 9, 1193-1204.
44. Bachur, N. R. Anthracycline antibiotic pharmacology and metabolism. Cancer Treat. Rep. 1979, 63, 817-820.
45. Burckhalter, J. H.; Tendwick, F. H.; Jones, E. M.; Jones, P. A.; Holcomb, W. F.; Rawlins, A. L. Aminoalkylphenols as antimalarials. II. (Heterocyclic-amino)-α-amino-o-cresols; the synthesis of camoquin. J. Am. Chem. Soc. 1948, 70, 1363-1373.
46. Denny, W. A. Acridine derivatives as chemotherapeutic agents. Curr. Med. Chem. 2002, 9, 1655-1665.
47. Yan, Z.; Sikri, S.; Beveridge, D. L.; Baranger, A. M. Identification of an aminoacridine derivative that binds to RNA tetraloops. J. Med. Chem. 2007, 50, 4096-4104.
48. Dorsjuren, D.; Burnette, A.; Gray, G. N.; Chen, X.; Zhu, W.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S. Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis. Antiviral Res. 2006, 69, 9-23.
49. Bond, A.; Reichert, Z.; Stivers, J. T. Novel and specific inhibitors of a poxvirus type I topoisomerase. Mol. Pharmacol. 2006, 69, 547-557.
50. Hagg, M.; Berndtsson, M.; Mandic, A.; Zhou, R.; Shoshan, M. C.; Linder, S. Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. Mol. Cancer Ther. 2004, 3, 489-497.
51. Virtual Computational Chemistry Laboratory (VCCLAB), http://www.vcclab. org, 2005.
52. Molinspiration Property Calculation Service, http://www.molinspiration. com, 2002.